<DOC>
	<DOCNO>NCT00507455</DOCNO>
	<brief_summary>A study evaluate safety co-administration solifenacin succinate tamsulosin hydrochloride men low urinary tract symptom ( LUTS ) bladder outlet obstruction ( BOO ) .</brief_summary>
	<brief_title>Solifenacin Succinate With Tamsulosin HCl Males With Lower Urinary Tract Symptoms Bladder Outlet Obstruction</brief_title>
	<detailed_description />
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Urinary Bladder Neck Obstruction</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>Diagnosed Lower Urinary Tract Symptoms ( LUTS ) Bladder Outlet Obstruction ( BOO ) BOO indication Bladder Outlet Obstruction Index ( BOOI ) ≥ 20 Patient total International Prostate Symptom Score ( IPPS ) score ≥ 8 ( Inclusion criterion Baseline also ) Patient maximum urinary flow rate ≤ 12 mL/sec , void volume ≥ 120 mL free flow representative assessment uroflowmetry . History urinary retention precede 12 month Current urinary tract infection ( UTI ) symptomatic recurrent UTI &gt; 3 episode within 12 month . Known clinical history diagnosis chronic inflammation , stone bladder ureter , cause outflow tract obstruction Known diagnosis history carcinoma previous pelvic radiation therapy , except nonmetastatic basal squamous cell carcinoma skin treat successfully Clinically significant cardiovascular cerebrovascular disease within 6 month prior Visit 1</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Lower Urinary Tract Symptoms</keyword>
	<keyword>Bladder Outlet Obstruction</keyword>
	<keyword>Treatment</keyword>
	<keyword>Solifenacin Succinate</keyword>
	<keyword>Tamsulosin hydrochloride</keyword>
</DOC>